Evaluation of a New System, VITEK 2, for Identification and Antimicrobial Susceptibility Testing of Enterococci

ABSTRACT We evaluated the new automated VITEK 2 system (bioMérieux) for the identification and antimicrobial susceptibility testing of enterococci. The results obtained with the VITEK 2 system were compared to those obtained by reference methods: standard identification by the scheme of Facklam and Sahm [R. R. Facklam and D. F. Sahm, p. 308–314, in P. R. Murray et al., ed., Manual of Clinical Microbiology, 6th ed., 1995] and with the API 20 STREP system and, for antimicrobial susceptibility testing, broth microdilution and agar dilution methods by the procedures of the National Committee for Clinical Laboratory Standards. The presence ofvanA and vanB genes was determined by PCR. A total of 150 clinical isolates were studied, corresponding to 60Enterococcus faecalis, 55 Enterococcus faecium, 26 Enterococcus gallinarum, 5 Enterococcus avium, 2 Enterococcus durans, and 2Enterococcus raffinosus isolates. Among those isolates, 131 (87%) were correctly identified to the species level with the VITEK 2 system. Approximately half of the misidentifications were for E. faecium with low-level resistance to vancomycin, identified asE. gallinarum or E. casseliflavus; however, a motility test solved the discrepancies and increased the agreement to 94%. Among the strains studied, 66% were vancomycin resistant (57 VanA, 16 VanB, and 26 VanC strains), 23% were ampicillin resistant (MICs, ≥16 μg/ml), 31% were high-level gentamicin resistant, and 45% were high-level streptomycin resistant. Percentages of agreement for susceptibility and resistance to ampicillin, vancomycin, and teicoplanin and for high-level gentamicin resistance and high-level streptomycin resistance were 93, 95, 97, 97, and 96%, respectively. The accuracy of identification and antimicrobial susceptibility testing of enterococci with the VITEK 2 system, together with the significant reduction in handling time, will have a positive impact on the work flow of the clinical microbiology laboratory.

[1]  J. Barenfanger,et al.  Clinical and Financial Benefits of Rapid Bacterial Identification and Antimicrobial Susceptibility Testing , 1999, Journal of Clinical Microbiology.

[2]  D. Rhoden,et al.  Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species , 1984, Journal of clinical microbiology.

[3]  Dominique Monnet,et al.  Evaluation of the VITEK 2 System for Rapid Identification of Medically Relevant Gram-Negative Rods , 1998, Journal of Clinical Microbiology.

[4]  B. Murray,et al.  Genes involved in the regulation of beta-lactamase production in enterococci and staphylococci , 1993, Antimicrobial Agents and Chemotherapy.

[5]  J. Waitz Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[6]  Mary Jane Ferraro,et al.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[7]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[8]  B. Murray,et al.  Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis. , 1983, The Journal of clinical investigation.

[9]  E. Cercenado,et al.  Characterization of clinical isolates of beta-lactamase-negative, highly ampicillin-resistant Enterococcus faecalis , 1996, Antimicrobial agents and chemotherapy.

[10]  M. Jacobs,et al.  Comparative evaluation of the API 20S system and the automicrobic system gram-positive identification card for species identification of streptococci , 1984, Journal of clinical microbiology.

[11]  G. Eliopoulos,et al.  High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium , 1988, Antimicrobial Agents and Chemotherapy.

[12]  D. Rhoden,et al.  Comparative evaluation of the API 20S and AutoMicrobic gram-positive identification systems for non-beta-hemolytic streptococci and aerococci , 1985, Journal of clinical microbiology.

[13]  R. Moellering Emergence of Enterococcus as a significant pathogen. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. French Enterococci and vancomycin resistance. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  P. Courvalin,et al.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR , 1995, Journal of clinical microbiology.

[16]  B. Murray The life and times of the Enterococcus , 1990, Clinical Microbiology Reviews.

[17]  M. Ferraro,et al.  Automated identification of gram-positive bacteria , 1982, Journal of clinical microbiology.

[18]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .